Akizawa T, Yamaguchi Y, Otsuka T, Reusch M, et al. A Phase 3, Multicenter, Randomized, Two-Arm, Open-Label Study of Intermittent Oral Dosing of Roxadustat for the Treatment of Anemia in Japanese Erythropoiesis-Stimulating Agent-Naive Chronic Kidney Disease Patients Not on Dialysis. Nephron 2020 Jun 24:1-11. doi: 10.1159/000508100.
PMID: 32580188